Virax Biolabs Group Ltd
VRAX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001885827
No open-market purchases or sales by Virax Biolabs Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $77.6K in total; no superinvestor holds it.
Holders of 5% or more of VRAX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Virax Biolabs Group Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Foster James Alexander Cunliffe | 13G/A | 8.30%368.6K shares | +1.00 ppfrom 7.30% | Oct 29, 20254 filings | Oct 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Virax Biolabs Group Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 202611:14 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.00M shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20269:42 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%823.9K shares | New | Dec 31, 2025 | SEC |
| Oct 29, 20255:16 PM ET | Foster James Alexander Cunliffe | 13G/A | 8.30%368.6K shares | +1.00 ppfrom 7.30% | Mar 31, 2025 | SEC |
| Oct 29, 20255:16 PM ET | Foster James Alexander Cunliffe | 13G/A | 7.30%319.9K shares | −5.60 ppfrom 12.90% | Sep 30, 2024 | SEC |
| Oct 29, 20255:11 PM ET | Foster James Alexander Cunliffe | 13G/A | 12.90%288.0K shares | −12.00 ppfrom 24.90% | Dec 31, 2023 | SEC |
| Oct 29, 20255:09 PM ET | Foster James Alexander Cunliffe | 13G | 24.90%288.0K shares | New | Dec 31, 2022 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Virax Biolabs Group Ltd shares.
No Form 144 notices for Virax Biolabs Group Ltd are on file.